T-cell priming in bone marrow: the potential for long-lasting protective anti-tumor immunity

By Schirrmacher V.   Feuerer M.   Fournier P.   Ahlert T.   Umansky V.   Beckhove P.  

Trends in Molecular Medicine, Vol. 9, Iss. 12, 2003-12 ,pp. : 526-534

Elsevier

Access to resources Recommend Favorite

B cell-mediated down-regulation of IFN-γ and IL-12 production induced during anti-tumor immune responses in the tumor-bearing state

By Wijesuriya R.   Maruo S.   Sou J-P.   Ogawa M.   Umehara K.   Yamashita M.   Ono S.   Fujiwara H.   Hamaoka T.  

International Immunology, Vol. 10, Iss. 8, 1998-08 ,pp. : 1057-1065

Oxford University Press

Access to resources Recommend Favorite

Effect of rituximab on the long-term outcome after high-dose therapy for relapsed B-cell non-Hodgkin’s lymphoma

By Hess Georg   Flohr Thomas   Kolbe Karin   Bonn Sarah   Schuler Martin   Derigs Hans   Huber Christoph  

Annals of Hematology, Vol. 85, Iss. 11, 2006-11 ,pp. : 769-779

Springer Publishing Company

Access to resources Recommend Favorite

Potent Systemic Antitumor Immunity Induced by Vaccination with Chemotactic-Prostate Tumor Associated Antigen Gene-Modified Tumor Cell and Blockade of B7-H1

By LI NING   QIN HANJUN   LI XIAOZHU   ZHOU CHUNXIA   WANG DONGMEI   MA WENBO   LIN CHEN   ZHANG YOUHUI   WANG SHENGDIAN   ZHANG SHUREN  

Journal of Clinical Immunology, Vol. 27, Iss. 1, 2007-01 ,pp. : 117-130

Springer Publishing Company

Access to resources Recommend Favorite

Dendritic cell-based cancer immunotherapies

By Fujii Shin-ichiro  

Archivum Immunologiae et Therapiae Experimentalis, Vol. 57, Iss. 3, 2009-06 ,pp. : 189-198

Springer Publishing Company

Access to resources Recommend Favorite